Granules India surges on receiving USFDA's approval for Ibuprofen Tablets

18 Sep 2015 Evaluate

Granules India is currently trading at Rs. 121.50, up by 6.10 points or 5.29% from its previous closing of Rs. 115.40 on the BSE.

The scrip opened at Rs. 119.60 and has touched a high and low of Rs. 123.00 and Rs. 119.50 respectively. So far 1,28,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 134.00 on 20-Aug-2015 and a 52 week low of Rs. 70.82 on 16-Dec-2014.

Last one week high and low of the scrip stood at Rs. 123.00 and Rs. 114.20 respectively. The current market cap of the company is Rs. 2,483.00 crore.

The promoters holding in the company stood at 48.47% while Institutions and Non-Institutions held 3.05% and 48.48% respectively.

Granules India has received USFDA approval for its Abbreviated New Drug Applications (ANDA) for Ibuprofen Tablets USP, 400 mg, 600 mg and 800 mg.

Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.


Granules India Share Price

593.90 -12.00 (-1.98%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.